Pfizer says patient died in oral RA drug study
(AP) -- Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug.
Apr 22, 2011
not rated yet
0
